Gilead completes Nycomed deal

GILEAD Sciences yesterday announced that Gilead Sciences Limited, a wholly-owned Irish subsidiary, has completed its acquisition of Cork- based Nycomed Limited, formerly known as Altana Pharma Limited.

Nycomed Limited has been conducting manufacturing and tabletting operations at the Cork facility.

Gilead intends to transfer its current operations in Dublin to this facility and utilise the site primarily for solid dose manufacturing of existing and future products and EU-based product packaging.

Gilead expects to retain distribution activities for Gilead products and customer service operations in Dublin.

Gilead and Nycomed Limited announced the planned acquisition on August 7 this year.

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercialises innovative therapeutics in areas of un-met medical need.